Article info
PDFCommentary
Prioritisation for therapies based on a disorder’s severity: ethics and practicality
- Correspondence to Dr Nigel S B Rawson, Independent Researcher, Saskatoon, Saskatchewan S7J 3L2, Canada; eastlakerg{at}gmail.com
Citation
Prioritisation for therapies based on a disorder’s severity: ethics and practicality
Publication history
- Received December 21, 2021
- Accepted December 21, 2021
- First published January 21, 2022.
Online issue publication
January 22, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020
- Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
- Cost-utility of direct transfer to angiography suite (DTAS) bypassing conventional imaging for patients with acute ischemic stroke in Spain: results from the ANGIOCAT trial
- Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database
- Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective
- Quality-adjusted life years
- NICE is dead; long live NICE
- Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence
- Generating evidence for new high-risk medical devices
- How to avoid unfair discrimination against disabled patients in healthcare resource allocation